Hepatitis C virus seroconversion among young injection drug users: relationships and risks
- PMID: 12447730
- DOI: 10.1086/345554
Hepatitis C virus seroconversion among young injection drug users: relationships and risks
Abstract
The present study examined reasons for the high incidence of hepatitis C virus (HCV) infection among young injection drug users (IDUs). IDUs <30 years old who tested negative for HCV antibody were enrolled in a prospective cohort. Risk factors for seroconversion were examined using time-dependent regression analyses: 48 of 195 IDUs seroconverted to HCV, for an incidence rate of 25.1/100 person-years (95% confidence interval, 18.7-32.9/100 person-years). Independent risk factors included sharing needles with an HCV-infected sex partner (borderline statistical significance, P=.11) or a person who was not a sex partner, sharing nonsterile drug-preparation equipment, pooling money with another IDU to buy drugs, and exchanging sex for money. Ubiquitous behaviors among young IDUs, such as the forming of injecting or sexual partnerships and consequent sharing of needles and drug preparation equipment, are risk factors for HCV. Interventions to reduce HCV transmission must recognize the importance of relationships on injecting risk.
Similar articles
-
Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.Hepatology. 2001 Jul;34(1):180-7. doi: 10.1053/jhep.2001.25759. Hepatology. 2001. PMID: 11431749
-
Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities.J Infect Dis. 2010 Feb 1;201(3):378-85. doi: 10.1086/649783. J Infect Dis. 2010. PMID: 20053137
-
Indications of immune protection from hepatitis C infection.J Urban Health. 2004 Mar;81(1):58-60. doi: 10.1093/jurban/jth088. J Urban Health. 2004. PMID: 15047784 Free PMC article.
-
Correlates of hepatitis C virus infections among injection drug users.Medicine (Baltimore). 1995 Jul;74(4):212-20. doi: 10.1097/00005792-199507000-00005. Medicine (Baltimore). 1995. PMID: 7623656 Review.
-
Hepatitis C virus infection in Scotland: epidemiological review and public health challenges.Scott Med J. 2006 May;51(2):8-15. doi: 10.1258/RSMSMJ.51.2.8. Scott Med J. 2006. PMID: 16722130 Review.
Cited by
-
Evidence-based consensus on the diagnosis, prevention and management of hepatitis C virus disease.World J Hepatol. 2015 Mar 27;7(3):616-27. doi: 10.4254/wjh.v7.i3.616. World J Hepatol. 2015. PMID: 25848486 Free PMC article. Review.
-
Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.J Urban Health. 2004 Sep;81(3):428-47. doi: 10.1093/jurban/jth128. J Urban Health. 2004. PMID: 15273266 Free PMC article.
-
Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.World J Gastroenterol. 2014 Sep 28;20(36):12722-33. doi: 10.3748/wjg.v20.i36.12722. World J Gastroenterol. 2014. PMID: 25278674 Free PMC article. Review.
-
Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA.Drug Alcohol Depend. 2014 Sep 1;142:239-44. doi: 10.1016/j.drugalcdep.2014.06.028. Epub 2014 Jul 4. Drug Alcohol Depend. 2014. PMID: 25034898 Free PMC article.
-
[Injecting without getting infected: injectors' strategies to prevent HIV and HCV.].Trastor Adict. 2007 Oct 1;9(4):260-268. doi: 10.1016/s1575-0973(07)75655-6. Trastor Adict. 2007. PMID: 21915175 Free PMC article. Spanish.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical